Il y a eu 50 transactions d'initiés récentes enregistrées pour Tactile Systems Technology, Inc. (TCMD), dont 26 achats et 21 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $2M.
Les initiés notables ayant une activité récente comprennent Pearson Andrea, Dodd Sheri Louise, Burns Kristie. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — TCMD
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-09 |
Pearson Andrea |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-09 |
Pearson Andrea |
Director |
Attribution de RSU |
852 |
- |
- |
852 |
| 2026-02-24 |
Dodd Sheri Louise |
Chief Executive Officer |
Vente Informative |
10,993 |
$28.94 |
$318.14K |
243,885 |
| 2026-02-24 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Vente Informative |
6,246 |
$28.94 |
$180.76K |
82,581 |
| 2026-02-24 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Vente Informative |
7,701 |
$28.94 |
$222.88K |
134,819 |
| 2026-02-23 |
Dodd Sheri Louise |
Chief Executive Officer |
Vente Informative |
537 |
$28.69 |
$15.41K |
254,878 |
| 2026-02-23 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Vente Informative |
160 |
$28.69 |
$4.59K |
88,827 |
| 2026-02-23 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Vente Informative |
196 |
$28.69 |
$5.62K |
142,520 |
| 2026-02-20 |
Dodd Sheri Louise |
Chief Executive Officer |
Attribution de RSU |
19,751 |
- |
- |
241,902 |
| 2026-02-20 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Attribution de RSU |
3,490 |
- |
- |
82,085 |
| 2026-02-20 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Attribution de RSU |
3,579 |
- |
- |
125,698 |
| 2026-02-19 |
Dodd Sheri Louise |
Chief Executive Officer |
Attribution de RSU |
48,672 |
- |
- |
222,151 |
| 2026-02-19 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Attribution de RSU |
6,194 |
- |
- |
78,595 |
| 2026-02-19 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Attribution de RSU |
23,008 |
- |
- |
122,119 |
| 2026-01-02 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Vente Informative |
5,139 |
$28.85 |
$148.26K |
72,401 |
| 2025-08-08 |
Dodd Sheri Louise |
Chief Executive Officer |
Vente Informative |
7,762 |
$12.36 |
$95.91K |
173,479 |
| 2025-05-12 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Vente Informative |
2,921 |
$9.94 |
$29.04K |
99,111 |
| 2025-05-08 |
Burke William W |
Director |
Vente Informative |
3,300 |
$9.67 |
$31.91K |
48,520 |
| 2025-05-08 |
Dodd Sheri Louise |
Chief Executive Officer |
Vente Informative |
3,149 |
$9.83 |
$30.95K |
181,241 |
| 2025-05-07 |
Burke William W |
Director |
Attribution de RSU |
16,078 |
- |
- |
51,820 |
| 2025-05-07 |
Volkart Carmen B |
Director |
Attribution de RSU |
16,078 |
- |
- |
37,698 |
| 2025-05-07 |
Huggenberger Raymond |
Director |
Attribution de RSU |
16,078 |
- |
- |
56,320 |
| 2025-05-07 |
Shafer David Brent |
Director |
Attribution de RSU |
16,078 |
- |
- |
48,822 |
| 2025-05-07 |
Asbury Valerie L. |
Director |
Attribution de RSU |
16,078 |
- |
- |
48,822 |
| 2025-05-07 |
Washington Boyd Vindell |
Director |
Attribution de RSU |
16,078 |
- |
- |
35,247 |
| 2025-05-07 |
King Laura G. |
Director |
Attribution de RSU |
16,078 |
- |
- |
19,048 |
| 2025-03-11 |
Reuvers Daniel L. |
Director |
Don (Reçu) |
68,162 |
- |
- |
68,162 |
| 2025-02-25 |
Reuvers Daniel L. |
Director |
Vente Informative |
28,338 |
$14.18 |
$401.85K |
214,604 |
| 2025-02-25 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Vente Informative |
6,468 |
$14.40 |
$93.16K |
77,540 |
| 2025-02-25 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Vente Informative |
2,066 |
$14.51 |
$29.98K |
102,032 |
| 2025-02-24 |
Reuvers Daniel L. |
Director |
Vente Informative |
10,938 |
$14.55 |
$159.15K |
242,942 |
| 2025-02-24 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Vente Informative |
4,830 |
$14.65 |
$70.75K |
84,008 |
| 2025-02-24 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Vente Informative |
3,778 |
$14.70 |
$55.54K |
104,098 |
| 2025-02-20 |
Reuvers Daniel L. |
Director |
Attribution de RSU |
15,853 |
- |
- |
253,880 |
| 2025-02-20 |
Dodd Sheri Louise |
Chief Executive Officer |
Attribution de RSU |
20,108 |
- |
- |
118,721 |
| 2025-02-20 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Attribution de RSU |
3,359 |
- |
- |
68,128 |
| 2025-02-20 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Attribution de RSU |
3,446 |
- |
- |
64,741 |
| 2025-02-20 |
King Laura G. |
Director |
Attribution de RSU |
2,970 |
- |
- |
2,970 |
| 2025-01-13 |
King Laura G. |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-08-12 |
Ferstler Sherri Lee |
Senior VP, Sales |
Vente Informative |
1,550 |
$13.07 |
$20.26K |
38,764 |
| 2024-08-07 |
Dodd Sheri Louise |
Chief Executive Officer |
Attribution de RSU |
64,959 |
- |
- |
98,613 |
| 2024-05-16 |
Birkemeyer Elaine M. |
Chief Financial Officer |
Vente Informative |
3,041 |
$13.68 |
$41.59K |
61,295 |
| 2024-05-08 |
Burke William W |
Director |
Vente Informative |
2,500 |
$14.06 |
$35.15K |
25,273 |
| 2024-05-08 |
Volkart Carmen B |
Director |
Attribution de RSU |
10,469 |
- |
- |
21,620 |
| 2024-05-08 |
Huggenberger Raymond |
Director |
Attribution de RSU |
10,469 |
- |
- |
40,242 |
| 2024-05-08 |
Shafer David Brent |
Director |
Attribution de RSU |
10,469 |
- |
- |
32,744 |
| 2024-05-08 |
Dodd Sheri Louise |
Director |
Attribution de RSU |
10,469 |
- |
- |
33,654 |
| 2024-05-08 |
Asbury Valerie L. |
Director |
Attribution de RSU |
10,469 |
- |
- |
32,744 |
| 2024-05-08 |
Washington Boyd Vindell |
Director |
Attribution de RSU |
10,469 |
- |
- |
19,169 |
| 2024-05-06 |
Burns Kristie |
Sr. VP Mktg & Clinical Affairs |
Vente Informative |
815 |
$14.37 |
$11.71K |
62,574 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
